Joseph Carleone - 28 Apr 2022 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Issuer symbol
SXT
Transactions as of
28 Apr 2022
Transactions value $
$0
Form type
4
Filing time
02 May 2022, 17:20:56 UTC
Previous filing
04 Apr 2022
Next filing
01 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXT Common Stock Award $0 +1.06K +6.93% $0.00 16.4K 28 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SXT Deferred Stock 14.5K 28 Apr 2022 Common Stock 14.5K Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock under Issuer's 2017 Stock Plan, as amended and restated.
F2 Includes shares of restricted stock held under Issuer's 2012 Non-Employee Directors Stock Plan, and shares held in a dividend reinvestment plan.
F3 Deferred stock converts to common stock on a one-for-one basis.
F4 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.